Orexo is a fully integrated specialty pharmaceutical company which has developed four products from idea to patient.
Products approved worldwide
Our drug delivery technologies improve pharmaceuticals
Partnerships are critical to our success
We will be recognized for the added value our products bring to patients and societies
Orexo’s share is listed on Nasdaq Stockholm Mid Cap and available as American Depository Receipts (ADRs) on OTCQX in the US.
Follow Orexo in social media
Sentynl Therapeutics owns the rights to the Abstral® pharmaceutical in the US
READ MORE- Abstral
READ MORE - Sentynl Therapeutics